AACR Special Conference on Optimizing Therapeutic Efficacy and Tolerability through Cancer Chemistry
American Association for Cancer Research (AACR) shared a post on X:
“AACRchemistry24 co-chairs Chudi O. Ndubaku and Philip Jones adjourned the American Association for Cancer Research (AACR) Special Conference on Optimizing Therapeutic Efficacy and Tolerability through Cancer Chemistry.
We thank the co-chairs—including Angela N. Koehler—for developing this outstanding meeting.”
Margaret Foti, Chief Executive Officer of the American Association for Cancer Research (AACR), reshared the post, adding:
“This spectacular program benefited from the critical contributions of the AACR Chemistry in Cancer Research Working Group.
We are grateful to the AACRCICR steering committee—under the leadership of chair Lori S. Friedman—for their assistance.”
Margaret Foti is the Chief Executive Officer of the American Association for Cancer Research (AACR). Starting her career at AACR as an editorial staff member for the journal Cancer Research, she advanced through various editorial and management positions. Under her leadership, the AACR launched nine major peer-reviewed journals, including Cancer Discovery and Cancer Immunology Research. Her focused and visionary leadership drives the AACR’s mission to advance cancer research and work towards the prevention and cure of cancer.
More posts featuring AACR and Margaret Foti.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023